A blood test could predict how men diagnosed with advanced prostate cancer respond to targeted disease treatments.
Agilent Technologies Inc. (NYSE: A) recently introduced OneSight, a new software platform designed to help researchers visualize and analyze chromosomal aneuploidies in cell-free DNA sequencing data.
A new, low-cost device could revolutionize DNA analysis in low-income areas. The paper-based system has demonstrated comparable efficacy to previous methods.
The slow, cumbersome and expensive process of detecting antibodies could be revolutionized by new research, which will help with the diagnosis of auto-immune and infectious disease including HIV and rheumatoid arthritis.
Chemists have reported a rapid, simple, inexpensive DNA-based test, which could aid in the development of point-of-care devices.
A team from The University of Arizona have built upon the PCR technique, producing a device which could reduce the diagnosis time for tissue infections.
Blood test could identify which breast cancer patients will suffer relapse months in advance.
New faster PCR system developed using light-based heating system.
Analysis of circulating tumor DNA in blood plasma may allow early detection of breast cancer metastasis.
A new technique has been developed for studying proteins, which could hold promise for use in point-of-care devices.